According to Piper Jaffray, Medtronic MDT price target is $44.
Piper Jaffray said that, while more negative focus on InFuse will likely continue to pressure spine division sales, the larger portion of MDT's spine business, core constructs, are trending upward. “Our price target of $44 is based on the stock trading at ~11x our C12 EPS estimate of $3.95.”
Watson Pharmaceuticals closed yesterday at $68.20.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareHealth Care EquipmentMedtronicPiper Jaffray
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in